-

 A Once-Daily Pill Shows Promise: Up to 12% Weight Loss in 36 Weeks




Imagine losing more than 12% of your body weight—without a single injection. That's the early promise of aleniglipron, a new GLP-1 pill that could shake up obesity treatment as we know it.

In a phase II clinical trial published in Nature Medicine, adults struggling with obesity or excess weight lost up to 12.1% of their body weight in just 36 weeks on this once-a-day pill. That’s not just a number—it’s the kind of result that could mean ditching the needle for a simple, daily tablet.

Aleniglipron works the same way as popular GLP-1 injectables like Wegovy and Ozempic, but here’s the twist: it’s a small molecule, not a peptide. In plain English, that means it’s a chemically made drug you swallow—no refrigeration, no needles, no complicated instructions. “Most meds you take—think aspirin or blood pressure pills—are small molecules,” explains Dr. Robert Kushner, one of the study’s authors and a longtime leader in obesity research. “You can take them with or without food, and even combine them with other drugs if needed.”

The study enrolled 230 adults, with an average age of 50, across 38 medical centers in the U.S. They were randomly assigned to one of three doses—45, 90, or 120 milligrams—or to a placebo. Over 36 weeks, those on the highest dose lost an average of 12.1% of their starting weight. Even the lowest dose produced a 9% drop. The placebo group, by comparison, saw just a 0.5% decrease.

As for side effects, most were mild to moderate stomach issues that became less common over time. About 1 in 10 participants stopped the treatment early, but no one developed liver problems linked to the drug.

Dr. Kushner says the results are a green light to move to larger phase III trials, with plans to slow dose increases to make the medication even easier to tolerate. “We didn’t spot any red flags or new safety concerns,” he says. “This could be a real step forward in how we treat obesity.”

If aleniglipron continues to shine, it could become a much more accessible option for millions of people—no prescription refrigeration, no injections, just a daily pill that fits right into your routine.

This research was funded by Structure Therapeutics.

Comments

Post a Comment

Popular posts from this blog

-
Image
DIABETES: PREVENTION AND MANAGEMENT Diabetes is a long-term health issue that affects millions of people, but it’s not a one-size-fits-all diagnosis. There are several types of diabetes, each with its own causes, risks, and management strategies. At its core, diabetes changes how your body handles insulin—a hormone made in the pancreas that lets your cells take in sugar from your blood and store it as glycogen for later. Without enough insulin or if your cells can’t use it properly, sugar stays in your bloodstream instead of fueling your body. The most common types are Type 1 and Type 2 diabetes. Type 1 is an autoimmune disease: your immune system mistakenly attacks the cells in your pancreas that make insulin. This form is less common and usually shows up earlier in life. There are also rarer forms, often tied to specific genes. Type 2 diabetes is the one most people know about—about 90% of diabetes cases fall into this category. It happens when your body becomes resistant to insulin ...
Read more
-
Image
THE   MEDITERRANEAN DIET : MAY HELP PREVENT DEMENTIA A new study brings some good news for anyone worried about dementia: what’s on your plate might matter more than your DNA. Even if you carry the genes that put you at the highest risk for Alzheimer’s, the right diet could help keep your brain healthier for longer. Scientists from Mass General Brigham, Harvard, and the Broad Institute tracked thousands of adults over several decades, examining what they ate and how their memory changed. Their findings? People who followed a Mediterranean-style diet—think lots of fruits and vegetables, whole grains, fish, olive oil, and nuts—were less likely to develop dementia and tended to keep their memory sharper as they aged. The effect was especially strong in people with two copies of the APOE4 gene, which is known to drive up the risk for Alzheimer’s. That’s a big deal, because carrying one copy of APOE4 makes you three to four times more likely to get Alzheimer’s. Two copies, and your risk...
Read more
-
Image
  PULLUPS AND CHIN-UPS: SIMPLE, POWERFUL, AND TRANSFORMATIVE  Pullups and chin-ups are more than just gym-class nostalgia—they’re a real benchmark for upper-body strength, power, and grip. Doesn’t matter if you’re new to working out or have been hitting the weights for years: these moves light up your back, arms, and forearms like nothing else, and the results carry over to just about everything you do. That’s why the military and law enforcement rely on them as a gold standard for functional strength [Beckham et al., 2018]. For many people, pullups seem out of reach. Maybe you’ve stood under that bar, given it a try, and felt like you were lifting a truck. It’s tempting to retreat to the lat pulldown machine, but here’s the thing: machines can’t match the full-body challenge of moving your entire weight. Pullups and chin-ups force your muscles—and your nervous system—to work together, teaching you to coordinate and generate real power with every rep. What’s actually going on ...
Read more